Gorry Paul R, Dunfee Rebecca L, Mefford Megan E, Kunstman Kevin, Morgan Tom, Moore John P, Mascola John R, Agopian Kristin, Holm Geoffrey H, Mehle Andrew, Taylor Joann, Farzan Michael, Wang Hui, Ellery Philip, Willey Samantha J, Clapham Paul R, Wolinsky Steven M, Crowe Suzanne M, Gabuzda Dana
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Virology. 2007 May 25;362(1):163-78. doi: 10.1016/j.virol.2006.11.025. Epub 2007 Jan 18.
Heterozygosity for the CCR5 Delta32 allele is associated with delayed progression to AIDS in human immunodeficiency virus type 1 (HIV-1) infection. Here we describe an unusual HIV-1 isolate from the blood of an asymptomatic individual who was heterozygous for the CCR5 Delta32 allele and had reduced levels of CCR5 expression. The primary virus used CCR5, CXCR4, and an unusually broad range of alternative coreceptors to enter transfected cells. However, only CXCR4 and CCR5 were used to enter primary T cells and monocyte-derived macrophages, respectively. Full-length Env clones had an unusually long V1/V2 region and rare amino acid variants in the V3 and C4 regions. Mutagenesis studies and structural models suggested that Y308, D321, and to a lesser extent K442 and E444, contribute to the broad coreceptor usage of these Envs, whereas I317 is likely to be a compensatory change. Furthermore, database analysis suggests that covariation can occur at positions 308/317 and 308/321 in vivo. Y308 and D321 reduced dependence on the extracellular loop 2 (ECL2) region of CCR5, while these residues along with Y330, K442, and E444 enhanced dependence on the CCR5 N-terminus compared to clade B consensus residues at these positions. These results suggest that expanded coreceptor usage of HIV-1 can occur in some individuals without rapid progression to AIDS as a consequence of changes in the V3 region that reduce dependence on the ECL2 region of CCR5 by enhancing interactions with conserved structural elements in G-protein-coupled receptors.
CCR5 Δ32等位基因的杂合性与人类免疫缺陷病毒1型(HIV-1)感染中艾滋病进展延迟相关。在此,我们描述了一种来自一名无症状个体血液中的不寻常HIV-1分离株,该个体为CCR5 Δ32等位基因杂合子,CCR5表达水平降低。该原始病毒利用CCR5、CXCR4以及一系列异常广泛的替代共受体进入转染细胞。然而,仅分别利用CXCR4和CCR5进入原代T细胞和单核细胞衍生的巨噬细胞。全长Env克隆具有异常长的V1/V2区域以及V3和C4区域中罕见的氨基酸变体。诱变研究和结构模型表明,Y308、D321以及在较小程度上K442和E444促成了这些Env的广泛共受体使用,而I317可能是一种补偿性变化。此外,数据库分析表明体内308/317和308/321位点可能发生共变。与这些位置的B亚型共有残基相比,Y308和D321降低了对CCR5细胞外环2(ECL2)区域的依赖性,而这些残基与Y330、K442和E444一起增强了对CCR5 N端的依赖性。这些结果表明,HIV-1共受体使用的扩展可发生在一些个体中,这些个体不会因V3区域的变化而迅速进展为艾滋病,V3区域的变化通过增强与G蛋白偶联受体中保守结构元件的相互作用而降低了对CCR5 ECL2区域的依赖性。